You cannot register for this webinar

This session will explore the clinical and economic value of IsoPSA in the assessment of prostate cancer risk. Attendees will gain insight into how IsoPSA enhances diagnostic accuracy, supports more informed biopsy decisions, and reduces unnecessary procedures. The lecture will also highlight real-world evidence demonstrating how IsoPSA aligns with value-based care principles, delivering both improved patient outcomes and measurable payor value—from the point of care to health plan adoption.